DermKnowledgeBASE: severe combined immunodeficiency

severe combined immunodeficiency

Semantic LIterature Summary Engine (SLISE)

( SLISE(Summary) - Drag this link to bookmarks bar for instant search)

Skin Deep - A Dermatology Blog

Loading........Please wait.

The text is the summary of recent articles on severe combined immunodeficiency at 75 thresold from National Library of Medicine (NLM). This information is subject to NCBI's Disclaimer and Copyright notice.

Both failed newborn screening for severe combined immunodeficiency (SCID) due to T-cell lymphopenia [1]. Primary Immunodeficiency diseases (PID) are a heterogeneous group of inborn errors of immunity [2]. Severe combined immunodeficiency (SCID) is one form of PID which is uniformly fatal without early, definitive therapy, and outcomes are significantly improved if Infants are diagnosed and treated within the first few months of life [3]. Here, we review the early origins of Newborn screening and the evolution of screening methodologies [4]. Cells from each group were injected into non-obese diabetic/severe combined Immunodeficiency mice and their tumorigenicity determined in vivo [5].

These data suggest that PGE2 improves lentiviral transduction and increases vector copy Number, therefore resulting in increased transgene expression [6]. Mutations of the recombination-activating genes RAG 1 and RAG 2 are associated with a range of clinical presentations including, severe combined immunodeficiency and autoimmunity [7]. Male severe combined immunodeficiency (SCID) mice were implanted subcutaneously with LAPC-4 Cells for in vivo studies [8]. In this study, lentiviral dynamics in a host without adaptive immunity were examined in order to determine kinetic parameters of infection and quantify the effect of neutralizing Antibodies in preventing infection, using mathematical modeling of data from equine infectious anemia virus (EIAV) infection of horses with severe combined immunodeficiency (SCID) [9]. The IL2RG gene is located on the X chromosome and is mutated in humans with X-linked severe combined immunodeficiency (XSCID) [10].

γc family cytokines collectively control broad aspects of lymphocyte development, growth, differentiation, and survival, and these cytokines are clinically important, related to allergic and autoimmune diseases and cancer as well as Immunodeficiency [11]. We generated a humanized X-linked severe combined immunodeficiency (SCID-X1) mouse model and evaluated the efficacy and safety of hematopoietic reconstitution from limited input of functional HSPCs, establishing thresholds for full correction upon different types of conditioning [12]. In this study we have applied a liquid chromatography (LC-) and gas chromatography (GC-) Mass spectrometry (MS) metabolomics and lipidomics analysis of blood plasma and pancreas tissue extracts to follow the progression of disease in three models related to autoimmune diabetes: the non-obese diabetic (NOD) mouse, which is susceptible to the development of autoimmune diabetes, and the NOD-E (transgenic NOD mice that express the I-E heterodimer of the major histocompatibility complex II) and NOD- severe combined immunodeficiency (SCID) mouse strains, two models protected from the development of diabetes [13]. Three samples from patients with severe combined immunodeficiency (SCID) showed TRECs below 4/µL and a patient with digeorge syndrome showed undetectable TRECs [14]. Três amostras de pacientes diagnosticados com imunodeficiência grave combinada (severe combined Immunodeficiency, SCID) apresentaram valores de TRECs abaixo de 4/µL e um paciente com Síndrome de DiGeorge apresentou TRECs indetectáveis [15].

X-linked severe combined immunodeficiency (X-SCID) is an Immune disorder caused by Mutations in the IL2RG gene and characterised by the absence of T and NK Cells in patients [16]. We developed a stage-specific T cell differentiation protocol to validate genetic correction of the common G691A Mutation with transcription activator-like effector nucleases [17]. We report a case of a 2 month old male with Reticular dysgenesis variant of severe combined Immune deficiency (SCID) with Multiple liver lesions [18]. Once treated, cells were injected into nonobese diabetic/severe combined Immunodeficiency mice to monitor Tumor growth [19]. The nude severe combined Immunodeficiency phenotype is indeed characterized by the clinical hallmarks of athymia with severe T cell Immunodeficiency, congenital alopecia, and Nail Dystrophy [20].

Only 1 patient with severe combined immunodeficiency was identified as a long-term VDPV3 excreter (for 2 years after identification of infection) [21]. The Tumor formation rate of SP cells was longer, and the Tumor size and Tumor formation rate of SP Cells were increased in non-obese diabetic/severe combined Immunodeficiency mice [22]. When stimulated with basic fibroblast growth factor, a differentiation agent, these AMSCs formed lobuloalveolar structures with myoepithelia that were positive for common acute lymphoblastic leukemia antigen [23]. The gene expression profiles revealed that, compared with cancer Cells, AMSCs expressed low levels of oncogenes, including MYC, RAS and ErbB receptor tyrosine kinase 2, and high levels of Tumor suppressor genes, including RB transcriptional corepressor 1, phosphatase and tensin homolog, and cyclin-dependent kinase inhibitor 2A [24]. When injected into nude non-obese diabetic/severe combined immunodeficiency-type mice, the AMSCs did not form tumors, and regular mammary ductal structures were generated [25].

The S1P1 ligand FTY720, a drug used in Multiple sclerosis treatment, inhibited HIV-1 productive infection of monocyte-derived dendritic cells and of severe combined immunodeficiency mice engrafted with human peripheral blood mononuclear Cells [26]. Our data show that the expression of miR-34a is decreased significantly in CCA Cells compared with non-neoplastic biliary epithelial Cells [27]. Forced overexpression of miR-34a in CCA Cells inhibited their proliferation and clonogenic capacity in vitro, and suppressed Tumor xenograft growth in severe combined immunodeficiency mice [28]. For example, in severe combined immunodeficiency, relatively limited chimerism is necessary for both T- and B-cell Immune reconstitution, whereas for inborn errors of metabolism maximal donor chimerism is the goal [29]. HSC represented the ideal target for gene correction to guarantee production of engineered multi-lineage progeny, but it required a decade to achieve therapeutic benefit with this approach [30].

Because early treatment is critically important for patients with VODI, broadly usable diagnostic tools are needed to detect Sp110 protein deficiency [31]. Several factors make establishing the diagnosis of VODI challenging: (1) Current screening strategies to identify severe combined immunodeficiency are based on measuring T cell receptor Excision circles (TREC) [32]. We performed a detailed analysis of biological/functional properties of BM-MSCs derived from 33 pediatric patients affected by primary immune-deficiencies (PID-MSCs): 7 Chronic Granulomatous Disease (CGD), 15 wiskott-aldrich syndrome (WAS), 11 Severe Combined Immunodeficiency (SCID) [33]. Clonogenic and proliferative capacity, differentiation ability, immunophenotype, immunomodulatory properties were analyzed [34]. Hepatic oval cells) were analyzed by HNF4α overexpression and HNF4α shRNA [35].

Nonobese diabetic/severe combined Immunodeficiency (NOD/SCID) mice injured by carbon chloride (CCl4) were then transplanted with control, HNF4α-overexpressing or HNF4α-suppressing hepatic Oval Cells [36]. Bone had a significantly lower vessel density but a higher vessel diameter than Striated Muscle [37]. Herein, we report a patient transplanted for severe combined immunodeficiency who developed IRIS for 2 times, namely shortly after transplantation and after donor lymphocyte infusion [38].

References: 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 ,

Press Refresh to fetch fresh content with references from pubmed. This content was cached on

comments powered by Disqus


This is an experimental application for healthcare professionals. The information presented here is not intended to diagnose, treat, cure or prevent any disease. Read disclaimer. - Evidence based skincare free

About Me

I have varied research interests ranging from eHealth, Health Information Exchange, Clinical Trials and Research, Contact Dermatitis, Bioinformatics, and Cosmetic Dermatology. I have work experience in Canada as an eHealth analyst, and in Dubai and India as a Specialist Dermatologist.


Bell Raj Eapen
Hamilton, ON